XML 51 R32.htm IDEA: XBRL DOCUMENT
v3.26.1

Shareholders' Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Shareholders' Equity [Abstract] |
Schedule of Information Regarding Outstanding Warrants to Purchase Shares | The following table summarizes information regarding outstanding warrants to purchase the Company’s ordinary shares as of December 31, 2025:
Issuance date |  | Number of outstanding Warrants |  |  | Exercise price per warrant |
December 2021 |  |  | 3,500 |  |  | $ | 200.0 |
January 2023 agent |  |  | 9,545 |  |  | $ | 68.75 |
November 2023 |  |  | 243,377 |  |  | $ | 17.50 |
November 2023 agent |  |  | 13,746 |  |  | $ | 19.13 |
August 2024 |  |  | 571,429 |  |  | $ | 22.50 |
August 2024 agent |  |  | 20,000 |  |  | $ | 21.90 |
April 2025 |  |  | 17,500 |  |  | $ | 15.0 |
July 2025 |  |  | 1,666,667 |  |  | $ | 4.67 |
July 2025 |  |  | 58,333 |  |  | $ | 7.50 |
|  |  | 2,604,097 |  |  |  |  |
Schedule of Company's Option Activity | The following table summarizes Company’s option activity during the year ended December 31, 2025:
|  | Number of options |  |  | Weighted average exercise price |  |  | Weighted average remaining contractual terms (in years) |  |  | Aggregate intrinsic value |
Outstanding at December 31, 2024 |  |  | 41,610 |  |  |  | 90 |  |  |  | 7.1 |  |  |  | - |
Grants |  |  | 8,000 |  |  |  | 16.01 |  |  |  | 10 |  |  |  | - |
Forfeited/expired |  |  | (77 | ) |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at December 31, 2025 |  |  | 49,533 |  |  |  | 87.31 |  |  |  | 6.6 |  |  |  | - |
Vested and expected to vest at December 31, 2025 |  |  | 49,533 |  |  |  | 87.31 |  |  |  | 6.6 |  |  |  | - |
Exercisable at December 31, 2025 |  |  | 25,497 |  |  |  | 143.98 |  |  |  | 5.7 |  |  |  | - |
Schedule of Fair value of Company’s Share Options Granted | The fair value of the Company’s share options granted was estimated using the binomial option pricing model using the following range assumptions:
Description |  | 2025 |  | 2024 |  | 2023
Risk-free interest rate |  | 4.04%-4.21% |  | 4.64%-5.09% |  | 3.95%-3.96%
Expected volatility |  | 79.56%-79.82% |  | 83.40%-83.94% |  | 84.30%-84.76%
Dividend yield |  | 0% |  | 0% |  | 0%
Contractual life (in years) |  | 10 |  | 9.75-10 |  | 10
Early Exercise Multiple (Suboptimal Factor) |  | 2.5 |  | 2.5 |  | 2.5
Schedule of Expenses Recognized Financial Statements | Expenses recognized in the financial statements:
|  | Year ended December 31, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Research and development |  | $ | 57 |  |  | $ | 75 |  |  | $ | 83 |
General and administrative (*) |  |  | 283 |  |  |  | 287 |  |  |  | 178 |
|  |  | 340 |  |  |  | 362 |  |  |  | 261 |
(*) | Including $141 and $112 share based compensation for services provided in 2025 and 2024, refer to note 9(b)(6) and note 9(b)(1), respectively.

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration